Opioid-Sparing Protocol Comparing With Opioid-based Protocol After Bilateral Total Knee Arthroplasty
Status:
Recruiting
Trial end date:
2020-08-20
Target enrollment:
Participant gender:
Summary
The concern for the opioid use in the total knee arthroplasty continues to rise in recent
decades. Historically, the total knee arthroplasty consumed high doses opioids in the
postoperative periods. Compared to the Opioid-Based patient controlled analgesia(PCA), the
opioid-sparing protocol may have benefits to decrease the concerns of the opioid use and
opioid-related complication and provides the equivalent efficacy for pain control. The
purpose of this trial in to provide a novel opioid-sparing protocol (OSP) to evaluate the
efficacy for pain control and reducing the immediate postoperative opioid consumption.